Childhood Cancer

You are here

Home » Grants » All grants tagged with "Acute Lymphoblastic Leukemia (ALL)"

All grants tagged with "Acute Lymphoblastic Leukemia (ALL)"

Trib2 in the Pathogenesis of T-ALL
Warren Pear, M.D., Ph.D.,
University of Pennsylvania
Innovation Grants, Awarded 2014
Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia
Mignon Loh, M.D.
University of California San Francisco
Innovation Grants, Awarded 2014
Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering
Hanno Hock, M.D., Ph.D.
Massachusetts General Hospital
Innovation Grants, Awarded 2014
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer
Stephen Gottschalk, M.D.
Baylor College of Medicine
Innovation Grants, Awarded 2014
Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL
Adolfo A. Ferrando, M.D., Ph.D.
Columbia University
Innovation Grants, Awarded 2014
Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit
Patricia Ernst, Ph.D.
University of Colorado Denver
Innovation Grants, Awarded 2014
Optimizing Engager T-cells for CD19+ Malignancies
Mireya Paulina Velasquez, MD
Baylor College of Medicine
Young Investigator Grants, Awarded 2014
Regulation and Function of IKZF1 in Normal and Malignant Pre-B cells
Emily Schulte
Washington University
POST Program Grants, Awarded 2014
Elucidating the Role of RUNDC3B Methylation in Pediatric Acute Lymphoblastic Leukemia
Robert Cristel
University of Missouri School of Medicine
POST Program Grants, Awarded 2014
Inhibition of BCL2 in T-cell ALL
Dennis Ea
University of Wisconsin - Madison
POST Program Grants, Awarded 2014

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »